-
What's next for Windlas Biotech, Devyani after listing?
Shares of Exxaro Tiles closed at Rs 132.20, at a premium of 10.16% compared with the issue price of Rs 120 per share
-
Krsnaa Diagnostics makes a tepid debut: What should investors do ?
Majority of brokerages had assigned a subscribe rating to the issue
-
Check GMPs allotment status for Devyani International, Krsnaa Diagnostics, Exxaro Tiles, Windlas Biotech IPOs
Here is the grey market premium for Devyani International Rs 56, Krsnaa Diagnostics Rs 290, Exarro Tiles Rs 9 and Windlas Biotech Rs 90
-
Female participation rises in IPOs: Paytm Money
Devyani International saw the highest share of applications from Paytm Money investors under 25 years of age
-
Day 2: Krsnaa Diagnostics IPO subscribed 5.35 times
The Rs 1,213.33-crore IPO received bids for 3,80,33,730 shares against 71,12,099 shares on offer
-
Krsnaa Diagnostics IPO: Here’s all you need to know
On the second day of the bidding, Krsnaa Diagnostics has been subscribed 5.33 times.
-
Krsnaa Diagnostic IPO sails through on Day 1
Proceeds from the issue will be used for financing the cost of establishing diagnostics centres in Punjab, Karnataka, HP and Maharashtra
-
Four new IPOs leave investors spoilt for choice; which one should you pick for your portfolio?
Krsnaa Diagnostics, Devyani International, Exxaro Tiles and Windlas Biotech are going to raise close to Rs 3,614 crore between August 4 and 6
-
Krsnaa Diagnostics IPO opens tomorrow
At the issue price of Rs 954, the issue looks fully priced. However, due to bullish sentiments, we may see IPO garnering good subscription.
-
Four IPOs to hit primary market on Aug 4; check GMP here
The largest franchisee of Pizza Hut, KFC and Costa Coffee in India has fixed a price band of Rs 86-90 a share for its Rs 1,838-crore IPO
